Back to SUSQUEHANNA INTERNATIONAL GROUP, LLP SUSQUEHANNA INTERNATIONAL GROUP, LLP

TBPHTBPH
Showing 8 of 29 quarters

Position history for SUSQUEHANNA INTERNATIONAL GROUP, LLPSUSQUEHANNA INTERNATIONAL GROUP, LLP's holdings in THERAVANCE BIOPHARMA INC

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds 341,579 shares of TBPH (THERAVANCE BIOPHARMA INC), worth $5.5M as of 2026-Q1. The position was increased (+1460.0% shares). TBPH represents 0.0% of SUSQUEHANNA INTERNATIONAL GROUP, LLP's portfolio.

Current Value

$5.5M

Current Shares

341,579

Total Value Change

+$5.4M

Total Shares Change

+326,380

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
341,579
+1460.0%
$5.5M0.0%$13.96
44
2025-Q4
Increased
21,896
+7.9%
$409,6740.0%$18.91
18
2025-Q3
Decreased
20,290
-59.3%
$296,2340.0%$14.43
0
2025-Q2
Decreased
49,851
-36.0%
$549,8570.0%$11.22
0
2025-Q1
Increased
77,926
+264.3%
$695,8790.0%$9.23
40
2024-Q4
Increased
21,392
+92.7%
$201,2990.0%$9.47
25
2024-Q3
Decreased
11,104
-26.9%
$89,4980.0%$8.10
0
2024-Q2
New
15,199
-
$128,8880.0%$8.48
34

Other major holders of TBPH: BAUPOST GROUP LLC/MA

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used